Targeted Drug Delivery to the Central Nervous System Using Extracellular Vesicles

Area of Science:

• Neuroscience
• Biotechnology
• Pharmacology

Background:

• The blood brain barrier (BBB) protects the central nervous system (CNS) but impedes drug delivery.
• Developing effective CNS drug delivery systems is crucial for treating neurological disorders.
• Artificial nanomedicine faces limitations in crossing the BBB and achieving targeted delivery.

Purpose of the Study:

• To review the limitations of artificial nanomedicine for CNS drug delivery.
• To explore the potential of natural extracellular vesicles (EVs) as therapeutic vehicles for targeted CNS delivery.
• To discuss recent advancements and future clinical feasibility of EV-based CNS drug delivery.

Main Methods:

• Literature review of artificial nanomedicine and extracellular vesicles (EVs) in CNS drug delivery.
• Analysis of EV engineering techniques for enhanced targeting and delivery.
• Brief overview of clinical studies in peripheral nervous system drug delivery for potential CNS strategies.

Main Results:

• Artificial nanomedicine presents challenges for effective CNS drug distribution.
• Extracellular vesicles (EVs) offer a promising natural alternative for targeted drug delivery across the BBB.
• Limited clinical trial data exists for CNS-targeted EV delivery, necessitating further investigation.

Conclusions:

• Extracellular vesicles (EVs) represent a viable strategy to overcome BBB drug delivery hurdles.
• Engineering and optimization of EVs are key to improving their efficacy for CNS therapeutics.
• Translating EV-based CNS drug delivery strategies to clinical practice requires further research and validation.